Mortality and Antidepressants Among Individuals With Autism Spectrum Disorder: A Population‐Based Cohort Study

A population-based cohort study of nearly 70,000 individuals with autism spectrum disorder found that those prescribed certain antidepressants had a significantly lower risk of premature death compared to non-users. This protective association was particularly pronounced for selective serotonin reuptake inhibitors and tricyclic antidepressants. The findings suggest that antidepressant treatment may improve survival outcomes in this vulnerable population, although further research is needed to confirm causality.

Read at onlinelibrary.wiley.com

All articles from 14 August 2026. Summaries are AI-generated and may contain errors; the linked article is the authority.